Clinical Trials Browser

Phase 3 × Pancreatic Neoplasms × methylnaltrexone × Clear all

NCT04151719 2021-05-07

An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

Phase 3 Withdrawn

Gastrointestinal

Pancreatic Neoplasms